Endo Health GmbH

Endo-App provides evidence-based content, behavioral interventions, symptom tracking, education modules, motivational support, and multimodal pain therapy techniques including cognitive behavioral therapy elements. It aims to improve quality of life for patients with endometriosis through self-management over recommended treatment duration of about 90 days. The app integrates validated questionnaires, diaries, guided exercises from multiple disciplines such as gynecology, physiotherapy, nutrition medicine etc., supporting holistic care. Endo Health GmbH develops the Endo-App, an innovative CE-certified prescription digital therapeutic designed to help women with endometriosis and adenomyosis manage symptoms through multimodal behavioral interventions delivered via smartphone. The app supports symptom tracking alongside educational content grounded in scientific guidelines. It has been officially recognized by German regulators under their DiGA program enabling reimbursement by statutory health insurance since late 2022. This positions them uniquely at the intersection of healthcare software/digital therapeutics within women's chronic disease management but does not operate as a traditional biotech/pharma drug developer with pipelines or clinical trials.